These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1333622)

  • 1. [Occurrence of antibodies against hepatitis C virus (anti-HCV) in patients on long-term hemodialysis].
    Sułowicz W; Dolezal M; Hejmo D; Gerhardt E; Ignacak E
    Przegl Lek; 1992; 49(1-2):67-8. PubMed ID: 1333622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis markers in hemodialysis patients].
    Leblebicioğlu H; Günaydin M; Cengiz K; Işlek I
    Mikrobiyol Bul; 1993 Oct; 27(4):321-6. PubMed ID: 7505387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.
    Ponz E; Campistol JM; Barrera JM; Gil C; Pinto J; Andreu J; Bruguera M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1371-2. PubMed ID: 1846466
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis and blood transfusion].
    Larsen J; Hetland G; Skaug K; Maeland A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of anti-HCV in patients on long-term hemodialysis.
    Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs non-dialyzed patients.
    Kumar H; Naqvi SA; Ahmed A; Hamid S
    J Pak Med Assoc; 1994 Feb; 44(2):28-30. PubMed ID: 8040988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-transfusional hepatitis in the city of Campinas, SP, Brazil. II. Presence of anti-HBc and anti-HCV antibodies in blood donor candidates and occurrence of post-transfusional hepatitis C in recipients of blood or derivates].
    Gonçales Júnior FL; Pedro Rde J; da Silva LJ; Boccato RS; Gonçales NS
    Rev Inst Med Trop Sao Paulo; 1993; 35(1):63-71. PubMed ID: 7506447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis].
    Kühnl P; Roggendorf M; Sibrowski W; Deinhardt F; Laufs R; Bornhövd K; Kalmar G; Seidl S; Böhm BO
    Beitr Infusionsther; 1990; 26():27-9. PubMed ID: 1703848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation.
    Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
    Ann Hematol; 1991; 62(2-3):68-73. PubMed ID: 1851645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan.
    Lin CY; Lin JY; Chen WP
    Nephron; 1993; 65(4):654. PubMed ID: 7508095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis B virus markers and anti-HCV antibodies in hemodialyzed patients].
    Illés M; Szontágh L; Gál G
    Orv Hetil; 1992 Jul; 133 Suppl 1():27-30. PubMed ID: 1630802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.